Market Update
Filed with ASX · · 4 pages · English
On 6ix: 6ix.com/news/market-update-161
MELBOURNE, 7 April 2021: Anatara Lifesciences Ltd (“Anatara” or “the Company”; ASX:ANR) provides an update on development and commercialisation activities for human health and animal health projects. Anatara is pleased that activities for the March quarter progressed favourably and near to anticipated timelines. There appears to be a wider appreciation of Anatara’s human health initiatives with a
Anatara Lifesciences Ltd on 6ix
Earlier from Anatara Lifesciences
- Anatara Lifesciences Ltd (ASX: ANR) Completion of Unmarketable Parcel Share Buy-Back
- Anatara Lifesciences Ltd Receives Ethics Approval to Start IBS Trial
- Anatara Lifesciences Ltd (ASX: ANR) R&D Tax Incentive Received
- Anatara Lifesciences Ltd (ASX: ANR) Successful Poultry Trial
- Anatara Lifesciences Ltd (ASX: ANR) Quarterly Cash Report
Later from Anatara Lifesciences
- Anatara announces Australian patent grant for Detach
- Appendix 4C - quarterly
- Anatara Lifesciences Limited (ASX: ANR) Chair Transition
- Anatara Lifesciences Limited (ASX: ANR) Monthly Activities Report
- Monthly Activities/Appendix 4C Cash Flow Report
Follow Anatara Lifesciences into a list and get an email when it puts out news.
Follow Anatara Lifesciences